Switch to:
More From Other Websites
THERAVANCE INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits May 20 2015
Theravance Biopharma Presents Additional Positive Phase 2b Study Data on TD-4208 for Treatment of... May 20 2015
THERAVANCE INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits May 18 2015
Theravance Biopharma Presents Positive Phase 2 Study Data on Velusetrag (TD-5108) for Treatment of... May 18 2015
THERAVANCE INC Financials May 15 2015
5 Stocks Insiders Love Right Now May 13 2015
10-Q for Theravance, Inc. May 10 2015
THERAVANCE INC Files SEC form 10-Q, Quarterly Report May 08 2015
General Releases May 07 2015
Theravance to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference May 07 2015
Theravance Inc Earnings Call scheduled for 5:00 pm ET today May 06 2015
THERAVANCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 06 2015
Theravance Reports First Quarter 2015 Financial Results May 06 2015
Q1 2015 Theravance Inc Earnings Release - After Market Close May 06 2015
Theravance Biopharma Announces New Employment Inducement Awards May 04 2015
U.S. FDA approves Glaxo, Theravance's Breo Ellipta asthma drug May 01 2015
THERAVANCE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 30 2015
Theravance Biopharma to Present at the Bank of America Merrill Lynch 2015 Health Care Conference Apr 30 2015
FDA approves BREO® ELLIPTA® for the treatment of adults with asthma in the US Apr 30 2015
FDA Approves BREO(R) ELLIPTA(R) for the Treatment of Adults With Asthma in the US Apr 30 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK